About TriBsyn®
Addressing Paresthesia: SR CarnoSyn® Technology
A key development in beta-alanine delivery was SR CarnoSyn® sustained-release technology. This formulation was designed to moderate the rate of absorption and reduce the likelihood of paresthesia while maintaining effective delivery of beta-alanine. This innovation supported more consistent use in clinical research settings and expanded investigation of beta-alanine supplementation across broader populations beyond traditional athletic applications.
Expanding Formulation Flexibility: TriBsyn®
As consumer needs evolved, demand increased for additional paresthesia-free delivery formats beyond tablets, including powders and functional applications.
TriBsyn® was developed as a next-generation beta-alanine ingredient designed for formulation flexibility. Using Hydro Oleo technology, TriBsyn® is engineered to support improved dispersion and bioavailability characteristics compared to standard beta-alanine powder forms. In a controlled clinical evaluation, TriBsyn® demonstrated 4× greater bioavailability with a reduction in paresthesia at the tested dose, along with improved delivery efficiency relative to conventional beta-alanine forms.
Applications and Use Cases
TriBsyn® is designed for use in a range of nutritional formulations, including ready-to-mix (RTM) powders, ready-to-drink (RTD) beverages, protein systems, dairy applications, gummies, and functional nutrition products.
These applications may support product formulations targeting muscle maintenance, healthy aging, and metabolic wellness. It may also be incorporated into products designed for individuals with increased nutritional needs, including those engaged in weight management programs where preservation of lean mass is an important consideration.
Visit our Study Citations page to learn more and read the study.
